Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease

BACKGROUND: The long-term efficacy and safety of aclidinium bromide, a novel, long-acting muscarinic antagonist, were investigated in patients with moderate to severe chronic obstructive pulmonary disease (COPD). METHODS: In two double-blind, 52-week studies, ACCLAIM/COPD I (n = 843) and II (n = 804...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jones, Paul W, Rennard, Stephen I, Agusti, Alvar, Chanez, Pascal, Magnussen, Helgo, Fabbri, Leonardo, Donohue, James F, Bateman, Eric D, Gross, Nicholas J, Lamarca, Rosa, Caracta, Cynthia, Gil, Esther Garcia
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3098801/
https://ncbi.nlm.nih.gov/pubmed/21518460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-12-55
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados